THE APEX TIMES
Alan Jackson opens up about Charcot-Marie-Tooth as he performs an emotional farewell concert in Nashville
The country star told audiences that a degenerative nerve condition, Charcot-Marie-Tooth disease, has affected his balance, leading him to take a step back from touring.
Alan Jackson returned to the stage in Nashville to perform what he described as a farewell concert, drawing widespread attention not only for the setlist, but for his personal remarks about the health issue that has shaped his recent years. CBS News reported that Jackson has a degenerative nerve condition that affects his balance, and that he had shared details of the diagnosis years earlier.
CBS News said Jackson told the audience that the condition is Charcot-Marie-Tooth disease, a disorder that can impact nerve function and lead to problems with mobility and balance. Jackson first revealed that he was diagnosed with the disease about a decade after he began dealing with symptoms, and he later described how the condition had become a factor in how he was able to perform.
The CBS News report also recalled that Jackson’s discussion of the disease dates back about five years. In that earlier period, he discussed how the disorder has affected him in day-to-day life and how it relates to his ability to move and remain steady during performances. In Nashville, the remarks were described as emotional, with the theme of closure and appreciation for fans.
The Nashville concert was presented as a tribute and a capstone moment for Jackson’s touring career. CBS News described the event in terms of both a musical sendoff and a public acknowledgement of the physical limitations he has been navigating. While the performance served as entertainment for attendees, it also functioned as a health update, connecting his stage presence to the medical condition he has discussed publicly.
Jackson’s public disclosure of his degenerative nerve condition comes as performers across genres have increasingly used high-profile platforms to discuss health challenges that can affect stamina, movement, and scheduling. In Jackson’s case, CBS News tied the balance-related symptoms directly to Charcot-Marie-Tooth disease, giving audiences more specific context for the changes fans have noticed over time.
Following the Nashville farewell concert, the next step for Jackson’s public-facing activities is expected to be clarified by his team and representatives, particularly regarding whether he will continue appearing in special events rather than touring. CBS News’s reporting placed the focus on the concert itself and the explanation Jackson gave for his situation, rather than announcing specific future appearances or a formal schedule.
Why It Matters
- Jackson’s comments connect a visible career shift to a specific medical diagnosis, offering audiences clearer context for performance-related changes.
- The farewell concert format highlights how major artists may use major venue appearances to communicate health and career transitions directly to fans.
- Charcot-Marie-Tooth is a chronic condition, and public disclosure can affect how fans, media, and event organizers plan future appearances and production needs.
- The concert also reflects the broader cultural role of country music venues and regional media coverage in shaping how major artists mark career milestones.
Key Facts
- Alan Jackson performed an emotional farewell concert in Nashville.
- CBS News reported Jackson has Charcot-Marie-Tooth disease, a degenerative nerve condition that affects his balance.
- CBS News said Jackson has discussed the disease publicly for about five years.
- The CBS News report said Jackson was diagnosed about a decade before his more recent public remarks.
- The Nashville event was described by CBS News as a tribute and a capstone moment for Jackson’s touring career.